D.C. Zika Tests Were Flawed

Share this content:
D.C. Zika Tests Were Flawed
D.C. Zika Tests Were Flawed

FRIDAY, Feb. 17, 2017 (HealthDay News) -- Two women in Washington, D.C., were incorrectly found to be negative for Zika virus last year due to flawed testing, health officials said Thursday.

The women have given birth, but the outcomes of their pregnancies are unknown. Their doctors have been contacted, NBC News reported. D.C. health officials said all 409 specimens that tested negative between July and December will be retested by U.S. Centers for Disease Control and Prevention labs. Of the 62 specimens retested so far, two came back positive for Zika.

Of the 409 specimens, 294 were from pregnant women and 115 were from non-pregnant women or men. Retesting all of the specimens could take up to four weeks, according to NBC News.

One of the problems with the test, which was suspended Dec. 14, was a mathematical error. The district's Public Health Laboratory is working with the CDC to correct the test and start using it again, NBC News reported.

More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

FDA Warns of Possible Heart Risks Linked to Clarithromycin

FDA Warns of Possible Heart Risks Linked to ...

Agency advising doctors to consider prescribing other antibiotics to patients with coronary heart disease

Artificial Intelligence May Help Prevent Physician Burnout

Artificial Intelligence May Help Prevent Physician Burnout

Many potential uses for AI, including improving searches and documentation, selecting treatment

Benzodiazepine Use Declining in Older Adults

Benzodiazepine Use Declining in Older Adults

Findings based on assessment of incidence, prevalence of use in three countries from 2010-2016

is free, fast, and customized just for you!

Already a member?

Sign In Now »